Mathew Clement

11PUBLICATIONS
45CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 13, 2026
Cytomegalovirus-induced T cell responses accelerate Alzheimer's disease progression in mice.

|Apr 03, 2024
The association of microbial infection and adaptive immune cell activation in Alzheimer's disease.

Mathew Clement

|Dec 15, 2023
Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion.

Sarah K Whiteside, Francis M Grant, Giorgia Alvisi

|Jul 13, 2023
Inhibitory IL-10-producing CD4+ T cells are T-bet-dependent and facilitate cytomegalovirus persistence via coexpression of arginase-1.

Mathew Clement, Kristin Ladell, Kelly L Miners

|Sep 08, 2022
IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses.

M Clement, J L Forbester, M Marsden

|Jul 17, 2021
CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor.

Mathew Clement, Lea Knezevic, Tamsin Dockree

Pageof 2

Frequent Collaborators

4 joint publications

Ian R Humphreys

4 joint publications

David A Price

2 joint publications

James E McLaren

2 joint publications

Richard J Stanton